Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 DecadesLaura J. Esserman, Linda S. Lindström|JAMA Oncology|2017Cited by 129
Long-term outcome in young women with breast cancer: a population-based studyHanna Fredholm, Irma Fredriksson, Kristina Magnusson et al.|Breast Cancer Research and Treatment|2016Cited by 128
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast CancerLinda S. Lindström, Christina Yau, Kamila Czene et al.|JNCI Journal of the National Cancer Institute|2017Cited by 90
Breast cancer in young women and prognosis: How important are proliferation markers?Hanna Fredholm, Irma Fredriksson, Linda S. Lindström et al.|European Journal of Cancer|2017Cited by 86
HM31 Breast cancer in young women – age a risk factor only in those not given chemotherapyHanna Fredholm, Irma Fredriksson, K. Magnusson et al.|The Breast|2014Cited by 1